Literature DB >> 31655998

Copy Number Variation in Tumor Cells and Extracellular DNA in Patients with Lung Adenocarcinoma.

D S Kutilin1, T G Airapetova2, P A Anistratov2, S P Pyltsin2, I A Leiman2, N S Karnaukhov2, O I Kit2.   

Abstract

Copy number variation of some gene loci in lung tumor cells extracted by laser capture microdissection and in cell-free DNA in the plasma of patients with lung cancer was analyzed for identification of potential molecular markers. Tissue specimens fixed in formalin and embedded in paraffin blocks (FFPE-blocks) from 90 patients and extracellular DNA from plasma samples of 70 patients and 30 donors were used. Copy number variation was assayed for 30 genes (BAX, BCL2, C-FLAR, P53, MDM2, CASP9, CASP3, CASP8, SOX2, OCT4, PIK3, MKI67, HV2, HIF1A1, XRCC1, MMP1, TERT, CTNNB1, KRAS, EGFR, GRB2, SOS1, MAPK1, STAT1, BRAF, FTO, and mir3678) and reference loci (ACTB, B2M, and GAPDH) by the real-time quantitative PCR. Changed copy numbers were detected for genes responsible for apoptosis regulation (BAX, P53, and CASP3), proliferation (SOX2), DNA reparation (XRCC1), oxidative phosphorylation (HV2), EGFR signaling pathway (GRB2, SOS1, MAPK1, STAT1, and BRAF), and for mir3678 gene in lung tumor cells and extracellular DNA.

Entities:  

Keywords:  apoptosis; gene copy number; laser microdissection; lung adenocarcinoma; real-time quantitative PCR

Mesh:

Substances:

Year:  2019        PMID: 31655998     DOI: 10.1007/s10517-019-04620-y

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

1.  Features of the Copy Number Variation of Certain Genes in Tumor Cells in Patients with Serous Ovarian Adenocarcinoma.

Authors:  D S Kutilin; M R Tsandekova; N V Porkhanova
Journal:  Bull Exp Biol Med       Date:  2021-01-16       Impact factor: 0.804

2.  Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma.

Authors:  Chunwei Ye; Haifeng Wang; Zhipeng Li; Chengxing Xia; Shunhui Yuan; Ruping Yan; Xiaofang Yang; Tao Ma; Xingqiao Wen; Delin Yang
Journal:  Transl Androl Urol       Date:  2021-07

Review 3.  Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management.

Authors:  Sadia Hassan; Adeeb Shehzad; Shahid Ali Khan; Waheed Miran; Salman Khan; Young-Sup Lee
Journal:  Biomedicines       Date:  2022-08-22

4.  Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.

Authors:  Wei Zhang; Shiqian Wan; Zhaohui Qu; Jing Ge; Chunxia Zhang; Chunfang Li; Yingchun Jiang
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.